Clinical Trial Update: ADH1 and ADH2 Disease Monitoring Study (DMS)

View source ↗

Summary

This clinical trial update notes a disease monitoring study for Autosomal Dominant Hypocalcemia evaluating two investigational agents, ADH-1 and ADH-2, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Hypocalcemia

Drugs mentioned

• ADH-1
• ADH-2

Snippet

Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company | Conditions: Autosomal Dominant Hypocalcemia | Status: ACTIVE_NOT_RECRUITING